Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

The virtual panel discussion will feature: Mr. Amir Reichman, CEO of Scinai, who will serve as moderator; Dr. Tamar Ben Yedidia, Chief Scientific Officer at Scinai; Prof. Michael Schoen, Director of Dermatology and Venerology at the University Medical Center Göttingen, Germany (UMG) and an independent medical consultant of Scinai; and Prof. Matthias Dobbelstein, Max Planck Institute Fellow and Department Head at UMG and a member of Scinai's Scientific Advisory Board. The webinar will be broadcast via Zoom. ...